Condition: Epidermolysis Bullosa Simplex · Ichthyosis · Genodermatosis · Sponsor: Centre Hospitalier Universitaire de Nice
The goal of this clinical trial is to learn about deucravacitinib treatment in adults with inflammatory epidermal genodermatoses . The main question it aims to answer are: describe efficacity and safety of this treatment. Participants will take treatments and have to use bullets during the study period.
This description comes directly from the study's public registry record.
christine chiaverini · 04.92.03.47.02 · chiaverini.c@chu-nice.fr
Always discuss trial participation with your own doctor first.
| CHU de Nice | Nice, CHU de NICE, France | Recruiting |
| APHP St Louis | Paris, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06136403